Oveporexton
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✗
Takeda has released Phase 3 study data for oveporexton, a new drug designed to treat the excessive daytime sleepiness associated with narcolepsy.
6 sources
6 articles
v 4
39d ago
◼ Archived
Business
🔮 fades ✓
The pharmaceutical company Takeda has released Phase 3 data for oveporexton, a transformative drug targeting narcolepsy type 1 symptoms.
6 sources
8 articles
v 5
40d ago
◼ Archived
Business
🔮 holds ✗
Takeda secures FDA approval for Orzeyful, launching a new class of treatments targeting the underlying cause of narcolepsy type 1.
10 sources
11 articles
v 9
74d ago
\n
\n
\n